Rakhshita Dhar
Directeur/Bestuurslid bij GRO Biosciences, Inc.
Oorsprong van het eerstegraads netwerk van Rakhshita Dhar
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.
10
| Holding Company | Pharmaceuticals: Major | 10 |
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology GRO Biosciences, Inc. develops genomically recoded organisms to express therapeutic proteins. The company was founded by George McDonald Church, Andrew D. Ellington, Daniel J. Mandell, Christopher J. Gregg, P. Benjamin Stranges, Marc J. Lajoie, and Ross Thyer in 2016 and is headquartered in Cambridge, MA.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Leaps by Bayer
 Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany.
5
| Subsidiary | Investment Managers | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rakhshita Dhar via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member | |
| AFFYMETRIX, INC. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Chairman | |
Formlabs, Inc.
 Formlabs, Inc. Industrial MachineryProducer Manufacturing Formlabs, Inc. engages in the design and manufacture of three-dimensional (3D) printing tools. Its products portfolio includes Form 3, Form 3L, Form 2, Wash + Cure, Form Cell, and Fuse 1. The firm offers products and services in the industries of engineering, manufacturing, education, entertainment, dental, jewelry, healthcare, and audiology. The company was founded by Maxim Boris Lobovsky, Natan Linder, and John D. Cranor III in 2011 and is headquartered in Somerville, MA. | Industrial Machinery | Private Equity Investor | |
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
Keywee, Inc.
 Keywee, Inc. Miscellaneous Commercial ServicesCommercial Services Keywee, Inc. provides content marketing and data mining services. It specializes in content marketing, natural language processing, data mining. The company was founded by Yaniv Makover in 2008 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Planet Labs, Inc.
 Planet Labs, Inc. Engineering & ConstructionIndustrial Services Planet Labs, Inc. operates earth-imaging satellites. The firm offers its imaging services for logistics, site development, crop monitoring, urbanization, natural resources, and asset management applications. The company was founded by William S. Marshall, Robert H. Schingler, Jr. and Christopher R. Boshuizen in 2010 and is headquartered in San Francisco, CA. | Engineering & Construction | Private Equity Investor | |
| Texas A&M University | College/University | Graduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree | |
| Georgetown University | College/University | Undergraduate Degree Doctorate Degree | |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Director/Board Member | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Color Health, Inc.
 Color Health, Inc. Packaged SoftwareTechnology Services Color Health, Inc. provides genetics services. It offers genetic testing services for hereditary cancers including breast, ovarian, colorectal, pancreatic, uterine, melanoma, prostate, and stomach cancers. The company was founded by Elad Gil, Othman Laraki, Taylor Sittler and Nish Bhat in 2013 and is headquartered in Burlingame, CA. | Packaged Software | Private Equity Investor | |
Velo3D US, Inc.
 Velo3D US, Inc. Industrial MachineryProducer Manufacturing Velo3D US, Inc. develops and manufactures metal laser sintering printing machines for 3D printing. It offers sapphire printer, flow software, and assure system. The company was founded by Benyamin Buller and Erel Milshtein in 2014 and is headquartered in Campbell, CA. | Industrial Machinery | Private Equity Investor | |
Freenome Holdings, Inc.
 Freenome Holdings, Inc. BiotechnologyHealth Technology Freenome Holdings, Inc. engages in the development of multiomics platform for early cancer detection. It develops simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. The company was founded by Charles Roberts, Riley Ennis, and Gabriel Otte and is headquartered in South San Francisco, CA. | Biotechnology | Private Equity Investor | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Uber Freight LLC
 Uber Freight LLC Packaged SoftwareTechnology Services Uber Freight LLC operates as a freight broker. It develops a mobile application that matches carriers with shippers to book the loads for hauling. The company is headquartered in San Francisco, CA. | Packaged Software | Private Equity Investor | |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Analyst | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Founder | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Boston Immune Technologies & Therapeutics, Inc.
 Boston Immune Technologies & Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Immune Technologies & Therapeutics, Inc. is a company based in MA that develops a novel class of antagonist antibodies targeting the TNF superfamily receptors for applications in oncology, inflammation, autoimmunity, and infectious disease. The company is based in Winchester, MA. The company is also developing additional TNF superfamily antibodies including CD40 antagonists for inflammation and CD30 antagonists for oncology. The company was founded by Russell LaMontagne and he has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Biotechnology | Director/Board Member Director/Board Member | |
| SOFI TECHNOLOGIES, INC. | Finance/Rental/Leasing | Private Equity Investor | |
Enveda Therapeutics, Inc.
 Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Duitsland | 2 |
| Ierland | 2 |
| Zwitserland | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 25 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 6 |
| Producer Manufacturing | 3 |
Operationeel
| Director/Board Member | 162 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 34 |
| Private Equity Investor | 27 |
| Founder | 21 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Helen Kim | 34 |
| Jürgen Eckhardt | 34 |
| Alan Colowick | 30 |
| Dror Berman | 29 |
| Edward Hurwitz | 27 |
| Lucio Iannone | 17 |
| Oleg Nodelman | 15 |
| R. Session | 13 |
| Shehnaaz Suliman | 11 |
| Bruce A. Beutel | 10 |
| Rana Al-Hallaq | 10 |
| David J. Lockhart | 7 |
| Ruzha Draganova | 6 |
| André Guillaume | 4 |
- Beurs
- Insiders
- Rakhshita Dhar
- Bedrijfsconnecties
